BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.92−0.01 (-0.91%)
Close on Nov 11, 2026Market cap $13.95MP/E –Yield –
BioCardia enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioCardia's enterprise value was $9.69M on Nov 11, 2026, against $10.10M a year earlier. Over the last 5 years it ranged from $3.53M to $804.19M, with a median of $12.97M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.69M | +21.6% |
| 2025 | Dec 31, 2025 | $7.97M | +61.7% |
| 2024 | Dec 31, 2024 | $4.93M | -97.7% |
| 2023 | Dec 29, 2023 | $212.20M | -61.6% |
| 2022 | Dec 30, 2022 | $552.65M | +16.3% |
| 2021 | Dec 31, 2021 | $475.04M | -25.5% |
| 2020 | Dec 31, 2020 | $637.86M | +73.4% |
| 2019 | Dec 31, 2019 | $367.82M | -46.2% |
| 2018 | Dec 31, 2018 | $684.15M | -48.5% |
| 2017 | Dec 29, 2017 | $1.33B | -63.4% |
| 2016 | Dec 30, 2016 | $3.64B | +1325.2% |
| 2015 | Dec 31, 2015 | $255.16M | -28.4% |
| 2014 | Dec 31, 2014 | $356.26M | +39.4% |
| 2013 | Dec 31, 2013 | $255.62M | +35.4% |
| 2012 | Dec 31, 2012 | $188.84M | -15.2% |
| 2011 | Dec 30, 2011 | $222.66M | – |
See a number that looks wrong?